当前位置:首页 - 行情中心 - 新光药业(300519) - 财务分析 - 现金流量表

新光药业

(300519)

  

流通市值:15.88亿  总市值:22.27亿
流通股本:1.14亿   总股本:1.60亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金142,554,277.3294,519,204.9270,171,742.76204,216,742.19
  收到其他与经营活动有关的现金1,588,283.461,077,327.3612,659,931.3112,460,655.66
  经营活动现金流入小计144,142,560.7895,596,532.26282,831,674.07216,677,397.85
  购买商品、接受劳务支付的现金35,571,500.3614,122,978.39122,907,289.196,969,962.25
  支付给职工以及为职工支付的现金17,768,212.6410,316,078.7735,584,418.5226,634,509.21
  支付的各项税费21,846,307.4912,924,641.4433,592,144.425,197,618.49
  支付其他与经营活动有关的现金11,178,251.726,429,139.4221,823,327.4217,287,251.89
  经营活动现金流出小计86,364,272.2143,792,838.02213,907,179.44166,089,341.84
  经营活动产生的现金流量净额57,778,288.5751,803,694.2468,924,494.6350,588,056.01
二、投资活动产生的现金流量:
  收回投资收到的现金6,880,0006,880,000--
  取得投资收益收到的现金3,739,905.031,059,551.055,941,645.953,080,095.34
  处置固定资产、无形资产和其他长期资产收回的现金净额1,600-29,50027,000
  收到的其他与投资活动有关的现金430,000,000140,000,000635,000,000345,000,000
  投资活动现金流入小计440,621,505.03147,939,551.05640,971,145.95348,107,095.34
  购建固定资产、无形资产和其他长期资产支付的现金211,346.7553,746.753,475,750.93,480,119.27
  支付其他与投资活动有关的现金430,000,00090,000,000850,000,000560,000,000
  投资活动现金流出小计430,211,346.7590,053,746.75853,475,750.9563,480,119.27
  投资活动产生的现金流量净额10,410,158.2857,885,804.3-212,504,604.95-215,373,023.93
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金1,000,000-1,000,0001,000,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计1,000,000-1,000,0001,000,000
  分配股利、利润或偿付利息支付的现金48,000,000-48,000,00048,000,000
  支付其他与筹资活动有关的现金1,000,000-1,000,0001,000,000
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计49,000,000-49,000,00049,000,000
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-48,000,000--48,000,000-48,000,000
五、现金及现金等价物净增加额20,188,446.85109,689,498.54-191,580,110.32-212,784,967.92
  加:期初现金及现金等价物余额311,836,015.14311,836,015.14503,416,125.46503,416,125.46
  期末现金及现金等价物余额332,024,461.99421,525,513.68311,836,015.14290,631,157.54
补充资料:
  净利润39,712,072.46-54,211,458.52-
  资产减值准备-236,649.38-435,419.57-
  固定资产和投资性房地产折旧6,745,580.55-14,445,503.35-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧6,745,580.55-14,445,503.35-
  无形资产摊销145,311.58-290,623.16-
  处置固定资产、无形资产和其他长期资产的损失--3,722.27-
  固定资产报废损失-1,415.93-42,236.22-
  投资损失-3,539,533.05--5,630,250.11-
  递延所得税103,183.58-211,038.78-
  其中:递延所得税资产减少103,183.58-211,038.78-
  存货的减少14,488,849.93-25,633,500.64-
  经营性应收项目的减少-320,093.22-4,926,744.05-
  经营性应付项目的增加655,756.11--25,442,627.08-
  现金的期末余额332,024,461.99-311,836,015.14-
  减:现金的期初余额311,836,015.14-503,416,125.46-
  现金及现金等价物的净增加额20,188,446.85--191,580,110.32-
公告日期2026-08-252026-04-212026-04-212025-10-28
审计意见(境内)标准无保留意见
TOP↑